The platelet-activating factor antagonist BB-882 does not improve tissue oxygen extraction in endotoxic shock

Journal of Critical Care

Volumn 13, Issue 2, 1998, Pages 81-90

  Spapen, H ^a   Zhang, H ^a   Verhaeghe, N ^a   Smail, N ^a   Vincent, J L ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ESCHERICHIA COLI ENDOTOXIN; LEXIPAFANT; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; BLOOD FLOW; BOLUS INJECTION; CONTINUOUS INFUSION; CONTROLLED STUDY; DOG; FEMALE; HEART INDEX; HEART LEFT VENTRICLE FILLING PRESSURE; HEART PERFORMANCE; HEART STROKE VOLUME; HEART TAMPONADE; HEMODYNAMICS; LUNG HEMODYNAMICS; MALE; NONHUMAN; PERICARDIUM; RESUSCITATION; SEPTIC SHOCK; TISSUE OXYGENATION;

EID: 0031838592     PISSN: 08839441     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0883-9441(98)80006-3     Document Type: Article

References (31)

1. Vincent J.-L. Van Der Linden P. Septic shock: Particular type of acute circulatory failure Crit Care Med 18 1990 S70 S74
2. Chan K.M. Abraham E. Septic shock Edwards J.D. Shoemaker W.C. Vincent J.L. Oxygen Transport: Principles and Practice 1993 WB Saunders London 274 293
3. McCuskey R.S. Urbaschek R. Urbaschek B. The microcirculation during endotoxemia Cardiovasc Res 32 1996 752 763
4. Parrillo J.E. Pathogenetic mechanism of septic shock N Engl J Med 328 1993 1471 1477
5. Dobrowsky R.T. Voyksner R.D. Olson N.C. Effect of SRI 63-675 on hemodynamics and blood PAF levels during porcine endotoxemia Am J Physiol 260 1991 H1455 H1465
6. Ono S. Mochizuki H. Tamakuna S. A clinical study on the significance of platelet-activating factor in the pathophysiology of septic disseminated intravascular coagulation insurgery Am J Surg 171 1996 409 415
7. Mathiak G. Szewczyk D. Abdullah F. Plateletactivating factor (PAF) in experimental and clinical sepsis Shock 7 1997 391 404
8. Dhainaut J.-F. Mira J.-P. Fiérobe L. Platelet-activating factor: Pathophysiological changes and therapeutic implications in sepsis Reinhart K. Eyrich K. Sprung C. Sepsis: Current Perspectives in Pathophysiology and Therapy 1994 Springer-Verlag Berlin, Heidelberg 397 413
9. Bussolino F. Camussi G. Aglietta M. Human endothelial cells are target for platelet-activating factor, I: Platelet-activating factor induces changes in cytoskeleton structures J Immunol 139 1987 2439 2446
10. Koltai M. Hosford D. Braquet P. Role of PAF and cytokines in microvascular tissue injury J Lab Clin Med 119 1992 461 466
11. Kingsnorth A.N. Galloway S.W. Formela L.J. Randomized, double-blind phase II trial of lexipafant, a plateletactivating factor antagonist in human acute pancreatitis Br J Surg 82 1995 1414 1420
12. Zhang H. Vincent J.-L. Oxygen extraction is altered by endotoxin during tamponade-induced stagnant hypoxia in the dog Circ Shock 40 1993 168 176
13. Samsel R.W. Schumacker P.T. Determination of the critical Oz delivery from experimental data: Sensitivity to error J Appl Physiol 64 1988 2074 2082
14. 1 increases oxygen extraction capabilities in experimental sepsis J Surg Res 57 1994 470 479
15. Zhang H. Spapen H. Nguyen D.N. Protective effects of N -acetyl l -cysteine in endotoxemia Am J Physiol 266 1994 H1746 H1754
16. Zhang H. Spapen H. Benlabed M. Pentoxifylline improves the tissue oxygen extraction capabilities during endotoxic shock Shock 2 1994 90 97
17. Zhang H. Spapen H. Manikis P. Tirilazad mesylate (U-74006F) inhibits effects of endotoxin in dogs Am J Physiol 268 1995 H1847 H1855
18. Whittaker M. PAF-receptor antagonists: Recent advances Curr Opin Therap Patents 2 1992 583 623
19. Formela L.J. Wood L.M. Whittaker M. Amelioration of experimental acute pancreatitis with a potent plateletactivating factor antagonist Br J Surg 81 1994 1783 1785
20. Galloway S.W. Kingsnorth A.N. Lung injury in the microembolic model of acute pancreatitis and amelioration by lexipafant (BB-882), a platelet-activating factor antagonist Pancreas 13 1996 140 146
21. Meenan J. Grool T.A. Hommes D.W. Lexipafant (BB-882), a platelet activating factor receptor antagonist, ameliorates mucosal inflammation in an animal model of colitis Eur J Gastroenterol Hepatol 8 1996 569 573
22. Abu-Zidan F.M. Walther S. Lennquist S. Role of plateletactivating factor antagonism in posthemorrhage septic shock in pigs J Trauma 41 1996 634 640
23. Abu-Zidan F.M. Walther S. Lennquist S. Modulation of lung injury by platelet-activating factor antagonism in nonhypotensive porcine endotoxemia Circ Shock 44 1995 148 153
24. Spapen H. Zhang H. Verhaeghe V. Treatment with a platelet activating factor antagonist has little protective effects during endotoxic shock in the dog Shock 8 1997 200 206
25. Yamanaka S. Miura K. Yukimura T. Putative mechanism of hypotensive action of platelet-activating factor in dogs Circ Res 70 1992 893 901
26. Kenzora J.L. Perez J.E. Bergmann S.R. Effects of acetyl glyceryl ether of phosphorylcholine (platelet activating factor) on ventricular preload, afterload, and contractility in dogs J Clin Invest 74 1984 1193 1203
27. Sybertz E.J. Watkins R.W. Baum T. Cardiac, coronary and peripheral vascular effects of acetyl glyceryl ether phosphoryl choline in the anesthetized dog J Pharmacol Exp Ther 232 1985 156 162
28. Yamanaka S. Iwao H. Yukimura T. Effect of the platelet-activating factor antagonist, TCV-309, and the cyclooxygenase inhibitor, ibuprofen, on the haemodynamic changes in canine experimental endotoxic shock Br J Pharmacol 110 1993 1501 1507
29. Kawamura M. Kitayoshi T. Terashita Z. Effects of TCV 309, a novel PAF antagonist, on circulatory shock and hematological abnormality induced by endotoxin in dogs J Lipid Med Cell Signal 9 1994 255 265
30. Okano S. Tagawa M. Urakawa N. Effect of platelet activating factor antagonist (TCV-309) on lung injury in dogs with experimentally endotoxin-induced shock J Vet Med Sci 57 1995 751 753
31. Earnest M.A. DiSimone A.G. Fletcher J.R. The effects of BN 52021, a PAF receptor antagonist, in canine endotoxemia Braquet P. The Ginkolides: Chemistry, Biology, Pharmacology and Clinical Perspectives vol 2. 1990 Prous Science Barcelona 463 470